Comparative Pharmacology
Head-to-head clinical analysis: AK FLUOR 10 versus ISOSULFAN BLUE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: AK FLUOR 10 versus ISOSULFAN BLUE.
AK-FLUOR 10% vs ISOSULFAN BLUE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Fluorescein sodium is a diagnostic dye that absorbs light in the blue spectrum (465-490 nm) and emits green-yellow fluorescence (520-530 nm). It is used to visualize blood flow, detect corneal abrasions, and assess vascular integrity by highlighting areas of leakage or damage.
Isosulfan blue is a dye that binds to serum proteins after intradermal injection, allowing visualization of lymphatic channels and lymph nodes during sentinel lymph node biopsy. It has no known pharmacological activity beyond its use as a visual contrast agent.
Intravenous injection: 5-10 mL (500-1000 mg fluorescein sodium) given rapidly over 4-5 seconds.
1-2 mL (10-20 mg) of a 1% solution injected subcutaneously or intradermally around the tumor or into the tumor, typically 3-5 minutes prior to sentinel lymph node biopsy.
None Documented
None Documented
Terminal elimination half-life is approximately 1-2 minutes in patients with normal renal function. This short half-life reflects rapid redistribution and renal clearance.
Terminal elimination half-life is approximately 20-30 minutes. Clinically, the dye is rapidly cleared from the plasma, which correlates with its short duration of action as a lymphographic agent.
Primarily renal (unchanged). Approximately 80-90% of an administered dose is excreted unchanged in urine within 24 hours. Biliary/fecal excretion is minimal (<5%).
Primarily excreted unchanged in bile via the hepatobiliary system (approximately 90%). Renal excretion accounts for less than 10% of the administered dose.
Category C
Category C
Diagnostic Dye
Diagnostic Dye